Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Ankylosing Spondylitis
Interventions
OTHER

no intervention

in real life of drug,dosage,frequency and duration

Trial Locations (18)

10128

Ospedale Mauriziano Umberto I, Torino

20122

Ospedale Ortopedico G. Pini, Milan

20132

Fondazione San Raffaele del Monte Tabor, Milan

33100

Policlinico Universitario, Udine

35128

Policlinico Universitario, Padua

37126

Ospedale Borgo Trento - Clinica Reumatologica, Verona

40138

U.O.S. Reumatologia - Azienda Ospedaliera Universitaria Policlinico Sant'Orsola-Malpighi, Bologna

44100

Arcispedale Sant'Anna, Ferrara

50143

Via Torregalli, 3, Florence

80131

Policlinico Universitario, II Universita, Napoli

90134

Divisione di Reumatologia, Palermo

90146

Policlinico Universitario P. Giaconne, Palermo

95100

Unita Operativa Semplice di Reumatologia, Catania

125128

Piazzale Spedali Civili, Brescia

09100

Policlinico Di Cagliari, Dipartimento Di Scienze Mediche, Cagliari

Unknown

Azienda USL 4 di Prato, Prato

Policlinico Umberto I, Roma

00128

Università Campus Bio-Medico di Roma- Policlinico Universitario Campus Bio-medico di Roma, Roma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01856569 - Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy | Biotech Hunter | Biotech Hunter